Shanxi Tianyu Pharmaceutical Co. Overview

  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 1

Shanxi Tianyu Pharmaceutical Co. General Information


Developer of medicines for treatment of sclerosis. The company mainly produces Lauromacrogol API and Lauromacrogol Injection, which are surgical medication for treatment of sclerosis. Its other products include sodium carbonate oral tonic and CoQ10 soft capsules. Its core technology is Lauromacrogol synthesis and its Lauromacrogol API and Lauromacrogol Injection own fully independent intellectual property rights in China.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • The hi tech Zone of Xi'an city
  • Road two No. 68 Software Park A block 3F
  • Xi’an
  • China
+86 029 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Shanxi Tianyu Pharmaceutical Co. Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC Completed Generating Revenue
To view Shanxi Tianyu Pharmaceutical Co.’s complete valuation and funding history, request access »

Shanxi Tianyu Pharmaceutical Co. Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Jun Yuan Capital Venture Capital Minority 000 0000 000000 0
To view Shanxi Tianyu Pharmaceutical Co.’s complete investors history, request access »